View news and innovations from PACK EXPO 2024
View all the latest news and innovations from PACK EXPO International 2024

Syntegon Enters Into Strategic Partnership with Bayer

The partnership will expand the development of new continuous manufacturing processes for oral solid dosage (OSD) forms.

Click

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The cooperation is based on the Xelum platform developed by the Syntegon subsidiary HĂĽttlin, which the partners intend to advance together and establish as a standard in the pharmaceutical industry. Its main advantage and a novelty in continuous pharmaceutical production is the previously unattained precise dosing of active ingredients. At the same time, fluid bed granulation provides granules with outstanding properties.

Uwe Harbauer, head of the business unit Pharma at Syntegon, confirms: "Together with Bayer, we will continue to develop our Xelum platform and tap its potential more quickly. This will enable us to align our technology even more closely with specific customer requirements. The goal is to realize a continuous line that covers all steps from powder to coated tablet."


Fill out the form below to request more information about Syntegon Enters Into Strategic Partnership with Bayer
New e-book on Multipacking and Case Packing
Read how to extend the life of your case packing equipment and best practices for efficient shrink bundling operation. Plus, learn the differences between wraparound & regular slotted containers.
Read More
New e-book on Multipacking and Case Packing